Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | GABRP | O00591 | 2/20 | 0.58 |
| ▸ | GABRD | O14764 | 2/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.58 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.58 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.58 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.58 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.58 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.58 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.58 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.58 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.58 |
| ▸ | GABRE | P78334 | 2/20 | 0.58 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.58 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.58 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.58 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26475764 | 1.00 | CYP1A2 (0.65) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL15601864 | 1.00 | CYP1A2 (0.65) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| Hydrochloric Acid SCHEMBL28246595 | 0.98 | CYP1A2 (0.62) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL29150389 | 0.84 | FFAR4 (0.52) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL15774679 | 0.82 | ALOX15 (0.46) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL487784 | 0.82 | ALOX15 (0.46) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL14895150 | 0.82 | ALOX15 (0.46) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL21026616 | 0.80 | ALDH1A1 (0.43) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL12203864 | 0.79 | GABRR1 (0.64) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL7321898 | 0.79 | CYP1A2 (1.00) | CYP1A2GABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1482940-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Pharmacia Corporation (US) | 2004-12-08 | — | — | EP | claimed |
| WO-2003028729-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2003-04-10 | — | — | WO | claimed |
| US-20230192904-A1 | BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. | 2023-06-22 | — | — | US | disclosed |
| US-11564971-B2 | Hyaluronic acid derivative having amino acid and steryl group introduced thereinto | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-31 | — | — | US | disclosed |
| EP-3919072-A1 | CANCER VACCINE PREPARATION | Mie University (JP) | 2021-12-08 | — | — | EP | disclosed |
| WO-2021195183-A1 | COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE | EXO THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| US-9950025-B2 | Compositions and methods for treatment of neoplastic disease | INNATE IMMUNOTHERAPEUTICS LIMITED (NZ) | 2018-04-24 | — | — | US | disclosed |
| WO-2017099823-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX, INC. (US) | 2017-06-15 | — | — | WO | disclosed |
| CN-103502317-B | Macroinitiators containing hydrophobic segments | 庄臣及庄臣视力保护公司 | 2017-02-08 | — | — | CN | disclosed |
| US-20160354424-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE | INNATE THERAPEUTICS LTD (NZ) | 2016-12-08 | — | — | US | disclosed |
| US-20150231268-A1 | HYALURONIC ACID DERIVATIVE HAVING AMINO ACID AND STERYL GROUP INTRODUCED THEREINTO | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-08-20 | — | — | US | disclosed |
| EP-1482940-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Pharmacia Corporation (US) | 2004-12-08 | — | — | EP | disclosed |
| EP-1432687-A2 | SUBSTITUTED 5-MEMBERED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Pharmacia Corporation (US) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003093242-A2 | SUBSTITUTED 5-MEMBERED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003028729-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354424-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE | IAPP, DNPEP, MICA | CYP1A2 4882/4885GABRP 2708/4885GABRD 2390/4885 |
| US-20150231268-A1 | HYALURONIC ACID DERIVATIVE HAVING AMINO ACID AND STERYL GROUP INTRODUCED THEREINTO | CD44, DAO, FUT6 | CYP1A2 2306/4885GABRP 510/4885GABRD 543/4885 |
| US-20230192904-A1 | BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF | ERBB2, ACP1, TK1 | CYP1A2 4154/4885GABRP 1751/4885GABRD 2559/4885 |
| US-11564971-B2 | Hyaluronic acid derivative having amino acid and steryl group introduced thereinto | CD44, DAO, FUT6 | CYP1A2 2306/4885GABRP 510/4885GABRD 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.